Compare KeyNeurotek Pharmaceuticals vs Virdante Pharmaceuticals
Customers evaluate the quality of KeyNeurotek Pharmaceuticals's products using the following success metrics.
Overview
KeyNeurotek Pharmaceuticals is based in Germany
KeyNeurotek Pharmaceuticals is a clinical stage small molecule company focused on autoimmune and CNS diseases.
Virdante Pharmaceuticals is based in United States
Virdante Pharmaceuticals is developing safer and more effective drugs for autoimmune and inflammatory diseases. The company's products incorporate a proprietary sialic switch technology to improve the anti-inflammatory properties of antibodies.
Demo Video
Leadership
Frank Striggow (Chief Executive Officer)
John Ripple (Chief Executive Officer)
Funding
Investors
IBG Beteiligungsgesellschaft, Deutsche Venture Capital
Venrock, Biogen Idec New Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because KeyNeurotek Pharmaceuticals has not claimed their profile.
Work for KeyNeurotek Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for KeyNeurotek Pharmaceuticals?
Claim your profile now.
Information not available because Virdante Pharmaceuticals has not claimed their profile.
Work for Virdante Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Virdante Pharmaceuticals?
Claim your profile now.